scholarly journals Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty

Author(s):  
Eun Byul Kwon ◽  
Young Suk Shim ◽  
Hae Sang Lee ◽  
Hwal Rim Jeong ◽  
Jin Soon Hwang
PEDIATRICS ◽  
1999 ◽  
Vol 104 (Supplement_5) ◽  
pp. 1010-1014
Author(s):  
Emily C. Walvoord ◽  
Ora Hirsch Pescovitz

The rationale underlying the use of gonadotropin-releasing hormone analogues (GnRHa) to treat patients with central precocious puberty is reviewed. GnRHa are now considered the treatment of choice for patients with central precocious puberty, but the adult heights that these patients attain often fall short of what would be expected according to their genetic potential. This has led to investigations of whether adding growth hormone to GnRHa therapy can improve adult height. The results of recent combination trials are presented and analyzed.


Sign in / Sign up

Export Citation Format

Share Document